SAN FRANCISCO-Friday 29 January 2021 [ AETOS Wire ]

(BUSINESS WIRE)-- Entering the Russian market, Andersen Global expands its coverage through a Collaboration Agreement with Moscow-based Lidings, a leading independent law firm.

Founded in 2006, the full-service firm works with local and international companies in various industries including market leaders, international investors and medium and large global businesses. Lidings has capabilities in tax, antitrust, banking and finance, employment, restructuring, real estate and litigation with a focus on corporate, disputes and intellectual property. Led by Managing Partner Andrey Zelenin, the law firm is recognized by Chambers and Partners, Legal 500, IFLR1000 and Best Lawyers.

“Over the years, we have built our reputation based on our in-depth knowledge of Russia’s intricate business culture and regulatory framework,” Andrey said. “Our practice has been dynamically growing and collabo ... Read more »

CAMBRIDGE, Mass. & OSAKA, Japan -Friday 29 January 2021 [ AETOS Wire ]

Mobocertinib, an oral targeted therapy, demonstrated clinically meaningful responses, with a confirmed objective response rate of 35% as assessed by investigator and 28% as assessed by an independent review committee (IRC)
Responses shown with mobocertinib were durable, with a median duration of response of 17.5 months as assessed by IRC
Results represent encouraging progress in a patient population for which no approved targeted therapies exist
(BUSINESS WIRE)-- Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced new data from the Phase 1/2 trial of mobocertinib (TAK-788) orally administered in previously treated patients with epidermal growth factor receptor (EGFR) Exon20 insertion+ metastatic non-small cell lung cancer (mNSCLC) will be presented as a late-breaking oral session at the International Association for the Study of Lun ... Read more »